Literature DB >> 4548834

In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.

L A Kirven, C Thornsberry.   

Abstract

Thirty-four strains of Haemophilus influenzae (20 ampicillin sensitive and 14 ampicillin resistant), mostly type b isolates from cerebrospinal fluid or blood, were tested for susceptibility to a combination of trimethoprim-sulfamethoxazole (TMP-SMZ) in a ratio of 1 part TMP to 19 parts SMZ. All strains were very susceptible to the TMP-SMZ combination, with minimal inhibitory concentrations ranging from 0.007-0.14 to 0.06-1.18 mug of TMP-SMZ per ml. There was little difference in the susceptibility of the ampicillin-sensitive and ampicillin-resistant strains to TMP-SMZ.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4548834      PMCID: PMC444752          DOI: 10.1128/AAC.6.6.869

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Antimicrobial susceptibility of Haemophilus influenzae.

Authors:  C Thornsberry; L A Kirven
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

2.  Ampicillin-resistant Haemophilus influenzae type B infection.

Authors:  M O Tomeh; S E Starr; J E McGowan; P M Terry; A J Nahmias
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

3.  Editorial: Should ampicillin be abandoned for treatment of Haemophilus influenzae disease?

Authors:  J D Nelson
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

4.  Haemophilus influenzae type B resistant to ampicillin. A report of two cases.

Authors:  W Khan; S Ross; W Rodriguez; G Controni; A K Saz
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

Review 5.  Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.

Authors:  S R Bushby
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

6.  Clinical, bacteriological, and immunological characterisation of ampicillin-resistant Haemophilus influenzae type B.

Authors:  M S Schiffer; J MacLowry; R Schneerson; J B Robbins; J W McReynolds; W J Thomas; D W Bailey; E J Clarke; E J Mueller; J Escamilla
Journal:  Lancet       Date:  1974-08-03       Impact factor: 79.321

7.  Resistance of Haemophilus influenzae to trimethoprim.

Authors:  J R May; J Davies
Journal:  Br Med J       Date:  1972-08-12

8.  Trimethoprim-sulfamethoxazole. Summary and comments on the conference.

Authors:  M Finland; E H Kass
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

9.  The possible scope of trimethoprim-sulphonamide treatment.

Authors:  L P Garrod
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

10.  Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.

Authors:  M C Bach; M Finland; O Gold; C Wilcox
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

  10 in total
  10 in total

Review 1.  Haemophilus influenzae: antibiotic susceptibility.

Authors:  C A Needham
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

2.  Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole.

Authors:  S I Pelton; P A Shurin; J O Klein; M Finland
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

3.  In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine.

Authors:  R Sinai; S Hammerberg; M I Marks; C H Pai
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

4.  Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.

Authors:  P C Fuchs; A L Barry; S D Brown
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

5.  Inoculum standardization in antimicrobial susceptibility testing: evaluation of overnight agar cultures and the Rapid Inoculum Standardization System.

Authors:  C N Baker; C Thornsberry; R W Hawkinson
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

6.  Modified microdilution susceptibility test for staphylococci, streptococci and Haemophilus spp.

Authors:  R J Fass; V L Helsel
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

7.  Susceptibility of Haemophilus influenzae isolates from blood and cerebrospinal fluid to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole.

Authors:  J E McGowan; P M Terry; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

8.  Influences of media and inocula on the in vitro susceptibility of Haemophilus influenzae to co-trimoxazole, ampicillin, penicillin, and chloramphenicol.

Authors:  M I Marks; G Weinmaster
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

9.  Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; L A Maher; A W Howell
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

10.  Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics.

Authors:  M G Bergeron; P Simard; P Provencher
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.